AstraZeneca braced for hostile bid
%VIRTUAL-SkimlinksPromo%Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its £63 billion takeover offer was spurned.
The UK company said the offer "substantially" undervalued the business, forcing Pfizer to consider its next move.